Autoimmune Thyroiditis and Vitamin D

Int J Mol Sci. 2024 Mar 9;25(6):3154. doi: 10.3390/ijms25063154.

Abstract

Hashimoto's thyroiditis (HT) is marked by self-tissue destruction as a consequence of an alteration in the adaptive immune response that entails the evasion of immune regulation. Vitamin D carries out an immunomodulatory role that appears to promote immune tolerance. The aim of this study is to elaborate a narrative review of the relationship between vitamin D status and HT and the role of vitamin D supplementation in reducing HT risk by modulating the immune system. There is extensive literature confirming that vitamin D levels are significantly lower in HT patients compared to healthy people. On the other hand, after the supplementation with cholecalciferol in patients with HT and vitamin D deficiency, thyroid autoantibody titers decreased significantly. Further knowledge of the beneficial effects of vitamin D in the prevention and treatment of autoimmune thyroid diseases requires the execution of additional randomized, double-blind, placebo-controlled trials and longer follow-up periods.

Keywords: Hashimoto thyroiditis; anti-thyroglobulin antibodies; anti-thyroid peroxidase; autoimmune thyroiditis; autoimmunity; immune cells; vitamin D; vitamin D deficiency; vitamin D supplementation.

Publication types

  • Review

MeSH terms

  • Hashimoto Disease* / drug therapy
  • Humans
  • Randomized Controlled Trials as Topic
  • Vitamin D / therapeutic use
  • Vitamin D Deficiency* / complications
  • Vitamin D Deficiency* / drug therapy
  • Vitamins / therapeutic use

Substances

  • Vitamin D
  • Vitamins

Grants and funding

This research received no external funding.